Ghent University Academic Bibliography

Advanced

A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies

Ahmad Awada, Christian D Rolfo, Sylvia Rottey, Laure Ysebrant de Lendonck, Wilfrled A Schroyens, Fritz Offner UGent, Karen Silence, Torsten Dreier, Mahan Moshir, Hans de Heard, et al. (2014) JOURNAL OF CLINICAL ONCOLOGY. 32(15, suppl.).
Please use this url to cite or link to this publication:
author
organization
year
type
conference (meetingAbstract)
publication status
published
subject
in
JOURNAL OF CLINICAL ONCOLOGY
J. Clin. Oncol.
volume
32
issue
15, suppl.
article number
abstract 3023
conference name
50th Annual meeting of the American Society of Clinical Oncology
conference location
Chicago, IL, USA
conference start
2014-05-30
conference end
2014-06-03
Web of Science type
Meeting Abstract
Web of Science id
000358613202914
JCR category
ONCOLOGY
JCR impact factor
18.443 (2014)
JCR rank
6/211 (2014)
JCR quartile
1 (2014)
ISSN
0732-183X
language
English
UGent publication?
yes
classification
C3
id
7004678
handle
http://hdl.handle.net/1854/LU-7004678
date created
2015-12-08 11:29:10
date last changed
2016-12-21 15:40:57
@inproceedings{7004678,
  articleno    = {abstract 3023},
  author       = {Awada, Ahmad and Rolfo, Christian D and Rottey, Sylvia and de Lendonck, Laure Ysebrant and Schroyens, Wilfrled A and Offner, Fritz and Silence, Karen and Dreier, Torsten and Moshir, Mahan and de Heard, Hans and Posters, Marc and Bron, Dominique and Thibault, Alain and Aftimos, Philippe G},
  booktitle    = {JOURNAL OF CLINICAL ONCOLOGY},
  issn         = {0732-183X},
  language     = {eng},
  location     = {Chicago, IL, USA},
  number       = {15, suppl.},
  title        = {A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies},
  volume       = {32},
  year         = {2014},
}

Chicago
Awada, Ahmad, Christian D Rolfo, Sylvia Rottey, Laure Ysebrant de Lendonck, Wilfrled A Schroyens, Fritz Offner, Karen Silence, et al. 2014. “A Phase I First-in-human Study of ARGX-110, a Monoclonal Antibody Targeting CD70, a Receptor Involved in Immune Escape and Tumor Growth in Patients with Solid and Hematologic Malignancies.” In Journal of Clinical Oncology. Vol. 32.
APA
Awada, A., Rolfo, C. D., Rottey, S., de Lendonck, L. Y., Schroyens, W. A., Offner, F., Silence, K., et al. (2014). A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies. JOURNAL OF CLINICAL ONCOLOGY (Vol. 32). Presented at the 50th Annual meeting of the American Society of Clinical Oncology.
Vancouver
1.
Awada A, Rolfo CD, Rottey S, de Lendonck LY, Schroyens WA, Offner F, et al. A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies. JOURNAL OF CLINICAL ONCOLOGY. 2014.
MLA
Awada, Ahmad, Christian D Rolfo, Sylvia Rottey, et al. “A Phase I First-in-human Study of ARGX-110, a Monoclonal Antibody Targeting CD70, a Receptor Involved in Immune Escape and Tumor Growth in Patients with Solid and Hematologic Malignancies.” Journal of Clinical Oncology. Vol. 32. 2014. Print.